Griffin Asset Management’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-3,323
Closed -$220K – 219
2022
Q1
$220K Hold
3,323
– – 0.03% 210
2021
Q4
$332K Sell
3,323
-184
-5% -$19K 0.04% 196
2021
Q3
$438K Sell
3,507
-321
-8% -$38.1K 0.06% 181
2021
Q2
$475K Hold
3,828
– – 0.06% 188
2021
Q1
$584K Sell
3,828
-750
-16% -$113K 0.07% 164
2020
Q4
$590K Buy
4,578
+41
+0.9% +$4.72K 0.08% 158
2020
Q3
$507K Sell
4,537
-2,370
-34% -$217K 0.08% 152
2020
Q2
$560K Sell
6,907
-724
-9% -$58.3K 0.09% 145
2020
Q1
$531K Buy
7,631
+70
+0.9% +$5.37K 0.1% 135
2019
Q4
$591K Sell
7,561
-200
-3% -$14.4K 0.08% 151
2019
Q3
$495K Sell
7,761
-3,575
-32% -$315K 0.08% 157
2019
Q2
$979K Buy
11,336
+154
+1% +$11.8K 0.12% 146
2019
Q1
$858K Buy
+11,182
New +$620K 0.12% 152

Other funds holding GH

Griffin Asset Management's GH Position: Q2 2022 in Review

Griffin Asset Management sold out of Guardant Health (GH) in Q2 2022, closing a stake of 3,323 shares — an estimated $220K sold.

Griffin Asset Management first reported a position in GH in Q1 2019 and held it in 13 quarters. The position peaked at $979K in Q2 2019. 332 funds tracked by Wall St. Rank hold GH as of Q2 2022.

  • Griffin Asset Management reported no remaining Guardant Health position as of Q2 2022 after selling out during the quarter.
  • Griffin Asset Management sold 3,323 Guardant Health shares in Q2 2022, an estimated $220K.
  • Griffin Asset Management first reported a position in Guardant Health in Q1 2019 and held it in 13 quarters.
  • Griffin Asset Management's Guardant Health position peaked at $979K in Q2 2019.
  • 332 funds tracked by Wall St. Rank held Guardant Health as of Q2 2022.

Based on Griffin Asset Management's 13F filing for Q2 2022, filed 19 Jul 2022.